Back
Open Access

Panel discussion – Treating the whole patient.

Session: Atrial fibrillation – A bystander or cause of morbidity and mortality: insights from the GARFIELD-AF registry
Topic: Atrial fibrillation (AF)
Speaker: Professor L. Mantovani (Monza, IT) Professor F. Verheugt (Amsterdam, NL)
Sponsored by Thrombosis Research Institute
Event: ESC Congress 2017

Congress Presentation

About the speakers

Professor Lorenzo Giovanni Mantovani

University of Milan-Bicocca, Monza (Italy)
1 presentation
0 follower

Professor Freek Verheugt

Hospital Onze Lieve Vrouwe Gasthuis, Amsterdam (Netherlands (The))
22 presentations
0 follower

7 more presentations in this session

GARFIELD-AF landmark: first-year outcomes of 52,000 prospective patients.

Speaker: Professor A. Kakkar (London, GB)

Access
Slides
Video
Thumbnail

Atrial fibrillation burden: morbidity and mortality.

Speaker: Doctor S. Goldhaber (Boston, US)

Access
Slides
Video
Thumbnail

Heart failure and atrial fibrillation: patient profile and outcomes in the real world.

Speaker: Doctor A. Turpie (Hamilton, CA)

Access
Slides
Video
Thumbnail

Management and outcomes in acute coronary syndromes with atrial fibrillation: where can we improve?

Speaker: Professor K. Fox (Edinburgh, GB)

Access
Slides
Video
Thumbnail

Chronic kidney disease and atrial fibrillation: geographic differences in routine care.

Speaker: Professor S. Goto (Isehara, JP)

Access
Slides
Video
Thumbnail

Access the full session

Atrial fibrillation – A bystander or cause of morbidity and mortality: insights from the GARFIELD-AF registry

Speakers: Professor L. Mantovani, Professor F. Verheugt, Professor A. Kakkar, Doctor S. Goldhaber, Doctor A. Turpie...
Access
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb